Fennec Pharmaceuticals (FENC) Other Non-Current Liabilities (2010 - 2018)
Fennec Pharmaceuticals (FENC) posted Other Non-Current Liabilities of $167000.0 for Q2 2018, little changed on a QoQ basis from $167000.0 in Q4 2017, and up 206.37% year-over-year from $54509.4 in Q2 2017.
Fennec Pharmaceuticals (FENC) Other Non-Current Liabilities (2010 - 2018) Analysis & Trends
Fennec Pharmaceuticals' Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $167000.0 for Q2 2018.
- Quarterly Other Non-Current Liabilities rose 206.37% year-over-year to $167000.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $167000.0 (up 206.37% YoY) and the FY2017 annual result came in at $167000.0, up 406.06% from the prior year.
- Other Non-Current Liabilities was $167000.0 for Q2 2018 at Fennec Pharmaceuticals, roughly flat from $167000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $5.5 million in Q1 2014 and bottomed at -$157000.0 in Q2 2017.
- A 5-year average of $1.2 million and a median of $167000.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2014 — Other Non-Current Liabilities jumped 2342.59% — and 2015, when it tumbled 97.34%.
- Fennec Pharmaceuticals' Other Non-Current Liabilities stood at $1.3 million in 2014, then slumped by 93.78% to $82000.0 in 2015, then plunged by 59.76% to $33000.0 in 2016, then jumped by 406.06% to $167000.0 in 2017, then changed by 0.0% to $167000.0 in 2018.
- Business Quant data shows FENC's Other Non-Current Liabilities at $167000.0 in Q2 2018, $167000.0 in Q4 2017, and -$157000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 167,000.00 |
| Dec 31, 2017 | 167,000.00 |
| Jun 30, 2017 | -157,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | 33,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 309,000.00 |
| Mar 31, 2015 | 694,000.00 |
| Dec 31, 2014 | 1.32 Mn |
| Sep 30, 2014 | 3.50 Mn |
| Jun 30, 2014 | 5.34 Mn |
| Mar 31, 2014 | 5.52 Mn |
| Dec 31, 2013 | 54,000.00 |
| Dec 31, 2012 | 96,000.00 |
| Dec 31, 2011 | 108,000.00 |
| Dec 31, 2010 | 86,000.00 |